肿瘤防治研究2026，Vol.53Issue(1)：73-78,6.DOI:10.3971/j.issn.1000-8578.2026.25.0607
ESMO临床获益量表与ASCO价值框架的解读与比较
Interpretation and Comparison of ESMO Magnitude of Clinical Benefit Scale and ASCO Value Framework
付奕霖 1朱影影 2李济宾3
作者信息
- 1. 510080 广州,中山大学公共卫生学院||广州,510060 中山大学肿瘤防治中心临床研究部
- 2. 510120 广州,中山大学孙逸仙纪念医院临床研究中心
- 3. 广州,510060 中山大学肿瘤防治中心临床研究部
- 折叠
摘要
Abstract
With continuous advances in cancer treatment,clinical oncology therapies have grown increasingly diverse.However,the rapid uptake of these novel therapies has driven up healthcare costs and complicated value assessments.The European Society for Medical Oncology(ESMO)and the American Society of Clinical Oncology(ASCO)have introduced the ESMO Magnitude of Clinical Benefit Scale and the ASCO Value Framework,respectively,to evaluate the clinical benefits and cost-effectiveness of anticancer interventions scientifically.This paper presents a detailed overview of the development,scoring structure,and practical application of both tools,with the goal of supporting clinical trial design and treatment decision-making in oncology.关键词
ESMO-MCBS/ASCO-VF/临床价值评估/净健康获益Key words
ESMO-MCBS/ASCO-VF/Clinical value assessment/Net health benefit分类
医药卫生引用本文复制引用
付奕霖,朱影影,李济宾..ESMO临床获益量表与ASCO价值框架的解读与比较[J].肿瘤防治研究,2026,53(1):73-78,6.
